Reliance Industries’ arm buys Strand Life Sciences’ stake for Rs 393 crore

By: |
September 04, 2021 5:15 AM

The company would also make a further investment of up to Rs 160 crore by March 2023, increasing its total investment to Rs 553 crore. Following this, the company’s stake will rise to about 80.3%, it said in a BSE filing.

The company acquired the 57% stake by buying 2.28 crore shares of Strand Life Sciences. The investment is part of RIL’s digital health initiatives and to foster affordable access to world-class technology and innovation led healthcare ecosystem in India, it said.The company acquired the 57% stake by buying 2.28 crore shares of Strand Life Sciences. The investment is part of RIL’s digital health initiatives and to foster affordable access to world-class technology and innovation led healthcare ecosystem in India, it said.

Reliance Strategic Business Ventures (RSBVL), a wholly-owned subsidiary of Reliance Industries (RIL), has acquired a 57.06% stake in Strand Life Sciences for Rs 393 crore in cash.

The company would also make a further investment of up to Rs 160 crore by March 2023, increasing its total investment to Rs 553 crore. Following this, the company’s stake will rise to about 80.3%, it said in a BSE filing.

The company acquired the 57% stake by buying 2.28 crore shares of Strand Life Sciences. The investment is part of RIL’s digital health initiatives and to foster affordable access to world-class technology and innovation led healthcare ecosystem in India, it said.

Set up in October 2000, Strand is into genomic testing with bioinformatics software and clinical research solutions to healthcare providers including clinicians, hospitals, medical devices manufacturers and pharmaceutical companies. Strand Life Sciences had posted a net profit of Rs 8.48 crore on a turnover of Rs 88.70 crore for FY21.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Lenders seek fresh bids for Videocon
2VIL promoters likely to infuse equity
3Supreme Court refuses to bail out hospitality sector